Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Other Operating Expenses: 2009-2013

Historic Other Operating Expenses for Cytokinetics (CYTK) over the last 2 years, with Sep 2013 value amounting to -$3.6 million.

  • Cytokinetics' Other Operating Expenses was N/A to -$3.6 million in Q3 2013 from the same period last year, while for Sep 2013 it was -$12.1 million, marking a year-over-year change of. This contributed to the annual value of -$24.5 million for FY2010, which is N/A change from last year.
  • Cytokinetics' Other Operating Expenses amounted to -$3.6 million in Q3 2013, which was down 0.00% from -$3.6 million recorded in Q2 2013.
  • Cytokinetics' Other Operating Expenses' 5-year high stood at $607.7 million during Q4 2010, with a 5-year trough of -$3.8 billion in Q2 2009.
  • Moreover, its 2-year median value for Other Operating Expenses was -$3.0 million (2011), whereas its average is -$3.8 million.
  • Within the past 5 years, the most significant YoY rise in Cytokinetics' Other Operating Expenses was 99.90% (2010), while the steepest drop was 166.54% (2010).
  • Over the past 4 years, Cytokinetics' Other Operating Expenses (Quarterly) stood at $5.7 million in 2009, then plummeted by 166.54% to $607.7 million in 2010, then plummeted by 100.40% to -$2.5 million in 2011, then reached -$3.6 million in 2013.
  • Its Other Operating Expenses was -$3.6 million in Q3 2013, compared to -$3.6 million in Q2 2013 and -$2.5 million in Q4 2011.